During the past decade, CCOP - Colorado Cancer Research Program conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 143 clinical trials were completed, i.e. on average, 715% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 56 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Colorado Cancer Research Program" #1 sponsor was "National Cancer Institute (NCI)" with 73 trials, followed by "Alliance for Clinical Trials in Oncology" with 47 trials sponsored, "Eastern Cooperative Oncology Group" with 42 trials sponsored, "SWOG Cancer Research Network" with 26 trials sponsored and "NSABP Foundation Inc" with 26 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Colorado Cancer Research Program" #1 collaborator was "National Cancer Institute (NCI)" with 164 trials as a collaborator, "Cancer and Leukemia Group B" with 16 trials as a collaborator, "SWOG Cancer Research Network" with 15 trials as a collaborator, "Eastern Cooperative Oncology Group" with 13 trials as a collaborator and "NCIC Clinical Trials Group" with 13 trials as a collaborator. Other collaborators include 66 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Colorado Cancer Research Program" are "Breast Cancer" (35 trials), "Lung Cancer" (16 trials), "Lymphoma" (16 trials), "Colorectal Cancer" (15 trials) and "Leukemia" (14 trials). Many other conditions were trialed in "CCOP - Colorado Cancer Research Program" in a lesser frequency.

Most popular intervention types in "CCOP - Colorado Cancer Research Program" are "Drug" (221 trials), "Other" (104 trials), "Biological" (96 trials), "Radiation" (36 trials) and "Procedure" (29 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "Quality-of-Life Assessment" (28 trials), "Paclitaxel" (26 trials), "placebo" (25 trials) and "cyclophosphamide" (23 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Colorado Cancer Research Program" are 190 trials for "All" genders, 53 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Colorado Cancer Research Program". undefined are not yet recruiting, undefined are recruiting, 57 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 169 completed trials in CCOP - Colorado Cancer Research Program, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Colorado Cancer Research Program, 4 "Phase 1" clinical trials were conducted, 107 "Phase 2" clinical trials and 141 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".